resident Trump’s promise to “slash the restraints” at the Food and Drug Administration appeared to lay down a marker for sweeping deregulation — and the Twittersphere reacted with both cheers and jeers.

During his address to a joint session of Congress on Tuesday night, Trump decried a “slow and burdensome” regulatory process that he said has too often delayed access to new treatments. He promised to bring about swift change. If there is an avalanche of new medicines, however, their manufacturers had better keep the costs in check, since Trump also vowed — without specifics — to bring down drug prices immediately. That particular bit of his speech drew a rare bipartisan standing ovation.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.